Fluoroquinolone Antibiotics: Patients With Myasthenia Gravis May Risk Increased Muscle Weakness
Fluoroquinolone Antibiotic Recall Summary Fluoroquinolone antibiotics are being recalled in Canada because they can cause increased muscle weakness in patients with myasthenia gravis. This recall affects fluoroquinolone antibiotic products distributed across Canada. Patients with myasthenia gravis who have been prescribed these antibiotics are included in this recall.
- Reason
- Product safety
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2011-11-07
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/be911403-1329-4c61-8ade-30baf60c1def